Work

Supplementary Figure 8 from A PD-L1/CD3 Bispecific Antibody Enhances the Antitumor Effects of Regorafenib against Colon Cancer

Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure 8 provides a putative model for improved colon cancer protection after REG/bsAb sensitization
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4412843799
Cites:
Cited by:
Related to: 10